Clinical trials for Acute leukemia
63 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2 / Phase 3
Acute leukemia
#NCT06860269
#2024-511437-35-00
GRAAPH-2024 - LAL à précurseurs B positifs (Phpos BCP-ALL)
Required histologic types
Acute lymphoblastic leukemia (ALL)
Required histologic sub types
B-cell (B-ALL)
Required genetic anomalies
Ph+ (Philadelphia chromosome positive)
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Excluded previous treatments
Chemotherapy
Targeted therapy
8 recruiting sites
Assistance Publique - Hôpitaux de Paris
Phase 2 / Phase 3
Acute leukemia
#NCT06860269
#2024-511437-35-00
GRAALL-2024/B - LAL-B à précurseurs B négatifs (Phneg BCP-ALL)
Required histologic types
Acute lymphoblastic leukemia (ALL)
Required histologic sub types
B-cell (B-ALL)
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Excluded previous treatments
Chemotherapy
Targeted therapy
8 recruiting sites
Assistance Publique - Hôpitaux de Paris
Phase 2 / Phase 3
Lymphoma
Acute leukemia
#NCT06860269
#2024-511437-35-00
Required histologic types
T cell lymphoma
Acute lymphoblastic leukemia (ALL)
Required histologic sub types
T-cell (T-ALL)
Required disease stage
Disseminated (stage III and IV)
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Excluded previous treatments
Chemotherapy
Targeted therapy
Monoclonal antibodies
8 recruiting sites
Assistance Publique - Hôpitaux de Paris
Phase 2
Acute leukemia
#NCT07007052
#2024-511003-42-00
Required histologic types
Blastic plasmacytoid dendritic cell neoplasm (BPDC...
Required renal function statuses
> 60 ml/min
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
8 recruiting sites
French Innovative Leukemia Organisation (FILO)
Phase 2
Lymphoma
CLL & Richter's syndrome
Acute leukemia
Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPN)
Multiple myeloma
#NCT04935684
Required histologic types
B cell lymphoma
T cell lymphoma
Hodgkin lymphoma
CLL (Chronic Lymphocytic Leukemia)
Symptomatic multiple myeloma
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Allogeneic stem cell transplant
Excluded previous treatments
Systemic Treatment-Naive
3 recruiting sites
CHU de Clermont-Ferrand
Phase 2
Acute leukemia
#NCT07007052
#2024-511003-42-00
Required histologic types
Blastic plasmacytoid dendritic cell neoplasm (BPDC...
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
9 recruiting sites
French Innovative Leukemia Organisation (FILO)
Phase 2
Acute leukemia
#NCT05260528
#2022-500295-60-00
Required histologic types
Acute myeloid leukemia (AML)
Required number of previous lines of therapy
None
31 recruiting sites
Centre Hospitalier Universitaire de Nice
Phase 2
Acute leukemia
#NCT06557421
#2024-514112-28-00
Required histologic types
Acute myeloid leukemia (AML)
Required number of previous lines of therapy
None
Required previous treatments
Chemotherapy
Targeted therapy
Excluded previous treatments
Allogeneic stem cell transplant
1 recruiting site
Institut Paoli Calmettes
Phase 2
Acute leukemia
#NCT06055621
#2023-505846-24-00
Required histologic types
Acute myeloid leukemia (AML)
Required central nervous system lesions
None
Required number of previous lines of therapy
1
Required previous treatments
Chemotherapy
Targeted therapy
Excluded previous treatments
Systemic Treatment-Naive
1 recruiting site
Institut Paoli Calmettes
Phase 2
Acute leukemia
#NCT06022003
#2022-501372-25-00
Required histologic types
Acute myeloid leukemia (AML)
Required central nervous system lesions
None
Treated / Controled
Required genetic anomalies
FLT3-ITD
FLT3-TKD
Required number of previous lines of therapy
1
2
Required previous treatments
Chemotherapy
Excluded previous treatments
Systemic Treatment-Naive
3 recruiting sites
French Innovative Leukemia Organisation (FILO)